Care pathways for serious heart defects
Part of Genetic & congenital, Heart & circulation, Lungs & breathing clinical trials.
This study helps connect people with serious congenital heart disease to specialized care and possible transplant centers through a network of hospitals. It aims to improve access to advanced treatments and better outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You or your child must have a heart problem present at birth (congenital heart disease).
- The heart condition must be serious, such as advanced heart or breathing failure, or high blood pressure in the lungs.
- You must be treated at a hospital that is part of the TORCH network, which can connect you to specialized heart or transplant centers.
- You must be able to give consent (or have a parent/guardian give permission) and to attend follow-up visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial helps connect adults with serious heart disease to specialized programs that may include advanced treatments or transplant. It focuses on finding the best care pathway for each person through a network of expert centers.
This trial is testing a new way to evaluate adults with advanced heart failure for a possible heart transplant. It aims to make the evaluation process smoother and faster through a network of participating centers.
This study is about creating a better, faster way to evaluate people with congenital heart disease for a heart or lung transplant. It tests a standardized process that helps doctors decide together if a transplant is the right option.
This study collects and shares anonymous information about adults being considered for a heart transplant because of a congenital (from birth) heart problem or an inherited heart muscle condition. The goal is to better understand these patients and support research that may improve care.
This trial tests a coordinated treatment plan for newborns with critical congenital heart disease, starting before birth and continuing after delivery. It aims to improve outcomes for babies who need two-ventricle repair surgery.
This study tests whether nurse-led or doctor-led education helps young people with congenital heart disease (a heart condition present from birth) transition from pediatric to adult care. The goal is to make this transition smoother and more accessible for all patients, including those with disabilities.
Hear when a new Congenital Heart Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.